Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 41

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT00984360Phase 2Completed
Study of Naltrexone for Methamphetamine Addiction
Methamphetamine Dependence
Principalinvestigator
NCT01149824Not ApplicableCompleted
Placebo Controlled Study of Sublingual Salvinorin A
Pharmaceutical Preparations
Principalinvestigator
NCT01529892Phase 4Withdrawn
The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine
Methamphetamine Metabolism, CYP2D6 Genotype
Principalinvestigator
NCT01867476Completed
Adherence Monitoring For Substance Abuse Clinical Trials
Medication Adherence
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00984360Phase 2PrincipalInvestigator

Study of Naltrexone for Methamphetamine Addiction

Methamphetamine Dependence
Completed
NCT01149824Not ApplicablePrincipalInvestigator

Placebo Controlled Study of Sublingual Salvinorin A

Pharmaceutical Preparations
Completed
NCT01529892Phase 4PrincipalInvestigator

The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine

Methamphetamine Metabolism, CYP2D6 Genotype
Withdrawn
NCT01867476PrincipalInvestigator

Adherence Monitoring For Substance Abuse Clinical Trials

Medication Adherence
Completed

All 4 trials loaded